Literature DB >> 6751038

Relationship of DNA tertiary and quaternary structure to carcinogenic processes.

P D Lipetz, A G Galsky, R E Stephens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6751038     DOI： 10.1016/s0065-230x(08)60425-x

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN： 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  7 in total

1.  Studies on DNA damage: discordant responses of rate of DNA disentanglement (viscosimetrically evaluated) and alkaline elution rate, obtained for several compounds. Possible explanations of the discrepancies.

Authors:  S Parodi; C Balbi; M L Abelmoschi; M Pala; P Russo; L Santi
Journal:  Cell Biophys       Date:  1983-12

2.  Polyamine depletion is associated with altered chromatin structure in HeLa cells.

Authors:  R D Snyder
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

3.  Cell cycle-dependent intervention by benzamide of carcinogen-induced neoplastic transformation and in vitro poly(ADP-ribosyl)ation of nuclear proteins in human fibroblasts.

Authors:  E Kun; E Kirsten; G E Milo; P Kurian; H L Kumari
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

4.  Distress and DNA repair in human lymphocytes.

Authors:  J K Kiecolt-Glaser; R E Stephens; P D Lipetz; C E Speicher; R Glaser
Journal:  J Behav Med       Date:  1985-12

5.  Characterisation of VP-16-induced DNA cleavage in oestrogen-stimulated human breast cancer cells.

Authors:  R J Epstein; P J Smith; J V Watson; N M Bleehen
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

Review 6.  Chemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on Carcinogens.

Authors: 
Journal:  Environ Health Perspect       Date:  1986-08       Impact factor: 9.031

7.  Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: II. DNA damage, repair and chromatin changes.

Authors:  P J Smith; J Mircheva; N M Bleehen
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.